The acquisition will enable BAL to leverage SFCL#39;s proficiency in developing cost-effective and distinctive manufacturing routes for off-patent molecules, it said.
The acquisition will enable BAL to leverage SFCL#39;s proficiency in developing cost-effective and distinctive manufacturing routes for off-patent molecules, it said.